Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Clinical Pharmacology and Therapeutics|November 2, 2004
Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosageB Meyer, F Traunmüller, A Hamwi, et al.
European Journal of Clinical Investigation|November 22, 2008
Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantationA Boehm, W R Sperr, G Leitner, et al.
Annals of Hematology|February 24, 2001
Effects of interferon-alpha2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosisG H Schernthaner, E Spanblöchl, W R Sperr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1993
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergenS Vrtala, W R Sperr, I Reimitzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2009
Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromesT Nösslinger, H Tüchler, U Germing, et al.
International Archives of Allergy and Immunology|September 26, 1997
Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506W R Sperr, H Agis, H Semper, et al.
Blood|December 15, 1994
Kit ligand/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisisP Valent, E Spanblöchl, H C Bankl, et al.
Leukemia Research|March 15, 2001
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromesF Wimazal, W R Sperr, M Kundi, et al.
Allergy|April 23, 2014
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the diseaseG Hoermann, K V Gleixner, G E Dinu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 6, 2003
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodiesN Mothes, M Heinzkill, K J Drachenberg, et al.
Pageof 13